1.Preferences of Medical Technology Students on COVID-19 Personal preventive behaviors and university safety protocols: A conjoint analysis
Ma. Camille Andrea Urbano ; Ria Anne Arellano ; Shanandra Rose Dizon ; Nicole Dominique Foja ; Jonas Galgana ; Lyka Gabrielle Terrado ; Paula Nadine Tuazon ; Florence Navidad
Journal of Medicine University of Santo Tomas 2024;8(1):1362-1370
The increase in coronavirus disease (COVID-19) cases in the Philippines has created an alarming issue in high-density public places, such as schools and universities. Personal preventive behaviors that the students exercise play a big part in whether such behaviors prevent or only predispose them even more to contracting the virus. Several factors may influence the personal preventive behaviors of an individual. These include attitude, awareness, personal beliefs, and culture concerning the disease. Through outlining these several factors, the researchers aim to identify the main attributes that determine students’ preferred COVID-19 personal preventive behavior and implemented precautionary measures.
The researchers used a two-part survey: socioeconomic and demographic followed by an orthogonal plan. The safety protocols implemented by the university were found to be the most important factor, followed by knowledge about the disease, communication channels, attitude, and social construct of the family. Thus, this follows that based on the attribute’s importance value, the students prefer safety protocols that are most implemented by the university while social construct of the family is the least preferred. These findings suggest that the safety protocols implemented by the university are the most important factor, hence, policy implementation and strengthening should be observed by the university.
COVID-19
;
Knowledge
;
Perception
;
Attitude
2.Awareness and possible treatment options toward COVID-19 among selected healthcare professionals in National Capital Region
Florence C. Navidad ; John Marlon P. Ancheta ; Joaquin V. Abundancia ; Angela Marie R. Ambal ; Ron Lemuel M. Brusola ; Josh Rogel L. Capco ; Julio Rafael Castillo ; Franzia Ellaine F. Castro
Philippine Journal of Health Research and Development 2022;26(1):33-41
Background:
Since December 2019, SARS-CoV-2, otherwise known as coronavirus disease 2019 (COVID-19), has caused worldwide panic and is now a serious problem. As the situation worsens, the need for an official cure becomes more crucial and different methods are being considered for treating infected COVID-19 patients.
Objectives:
This study aimed to emphasize and further elaborate on the existing and possible treatment methods against COVID-19 and assess the awareness of healthcare professionals (doctors, medical technologists, and nurses) on the treatments for COVID-19.
Methodology:
The study utilized an exploratory sequential mixed methods design following the treatment and misinformation theories models. The respondents were selected based on inclusion and exclusion criteria and recruited through the snowball sampling technique. The study used an adapted survey questionnaire on the pathophysiology of COVID-19 and possible treatment options. Descriptive statistical analysis for quantitative data and open thematic coding is used in an online qualitative deductive data analysis.
Results:
Based on the data, webinars, lectures, and discussions were the primary source of information among healthcare professionals. Most of the respondents showed proficiency with remdesivir among investigational selective medicines. Chloroquine was the top choice among selected repurposed drugs. They were aware of the convalescent plasma therapy that uses antibodies from the blood plasma of recovered COVID-19 patients. They were not aware of the different herbal treatments used to treat COVID-19.
Conclusion
Hence, chloroquine (repurposed drug), remdesivir (investigational drug), and convalescent plasma (adjunctive therapy) are the most well-known treatments for COVID-19. Most of the respondents were aware of the action and side effects of chloroquine, remdesevir, and convalescent plasma therapy.
COVID-19
;
Drugs, Investigational
;
Herbal


Result Analysis
Print
Save
E-mail